-
CytomX Therapeutics Announces Pricing of Public Offering of Common Stock
-
CytomX Therapeutics (CTMX) Announces Proposed $125M Share Offering
-
CytomX Therapeutics Announces Proposed Public Offering of Common Stock
-
Citi Starts CytomX Therapeutics (CTMX) at Buy
-
CytomX Appoints Matthew Young to Board of Directors